Getein Biotech Inc (SHG:603387) — Stock Price
Getein Biotech Inc (SHG:603387) is currently trading at CN¥9.32 CNY, up 0.76% today. Over the past 52 weeks, shares have ranged between CN¥7.52 and CN¥10.65. This page tracks Getein Biotech Inc's live share price on the SHG exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Getein Biotech Inc stock valuation.
Getein Biotech Inc (603387) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Getein Biotech Inc's daily closing share price and trading volume on the SHG exchange over the past year, giving a clear view of recent price momentum and liquidity.
Getein Biotech Inc Income Statement — Revenue, Profit & Earnings by Year
Getein Biotech Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥1.05 Billion | CN¥1.16 Billion | CN¥1.37 Billion | CN¥1.82 Billion | CN¥1.40 Billion |
| Cost of Revenue | CN¥317.73 Million | CN¥374.39 Million | CN¥479.71 Million | CN¥671.56 Million | CN¥485.42 Million |
| Gross Profit | CN¥733.99 Million | CN¥790.41 Million | CN¥889.45 Million | CN¥1.15 Billion | CN¥916.29 Million |
| Research & Development | CN¥157.40 Million | CN¥181.21 Million | CN¥217.99 Million | CN¥223.22 Million | CN¥163.39 Million |
| SG&A | CN¥79.57 Million | CN¥95.70 Million | CN¥106.83 Million | CN¥103.94 Million | CN¥90.57 Million |
| Total Operating Expenses | CN¥794.71 Million | CN¥532.36 Million | CN¥582.86 Million | CN¥587.05 Million | CN¥463.50 Million |
| Operating Income | CN¥257.01 Million | CN¥258.05 Million | CN¥306.59 Million | CN¥563.26 Million | CN¥452.79 Million |
| EBITDA | — | CN¥354.73 Million | CN¥407.92 Million | CN¥642.06 Million | CN¥513.39 Million |
| EBIT | — | CN¥268.85 Million | CN¥322.42 Million | CN¥577.13 Million | CN¥465.95 Million |
| Interest Expense | CN¥12.09 Million | CN¥15.42 Million | CN¥17.48 Million | CN¥17.15 Million | CN¥15.99 Million |
| Income Before Tax | CN¥227.69 Million | CN¥253.43 Million | CN¥304.94 Million | CN¥559.98 Million | CN¥451.63 Million |
| Income Tax Expense | — | CN¥23.55 Million | CN¥20.86 Million | CN¥56.03 Million | CN¥39.62 Million |
| Net Income | CN¥220.66 Million | CN¥223.64 Million | CN¥279.77 Million | CN¥498.91 Million | CN¥398.99 Million |
Getein Biotech Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Getein Biotech Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥3.76 Billion | CN¥3.71 Billion | CN¥3.77 Billion | CN¥3.68 Billion | CN¥3.14 Billion |
| Total Current Assets | CN¥2.30 Billion | CN¥1.86 Billion | CN¥2.15 Billion | CN¥2.40 Billion | CN¥2.37 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥912.63 Million | CN¥648.88 Million | CN¥451.91 Million | CN¥511.14 Million | CN¥612.68 Million |
| Net Receivables | CN¥359.52 Million | CN¥407.75 Million | CN¥478.61 Million | CN¥496.91 Million | CN¥445.96 Million |
| Inventory | CN¥183.83 Million | CN¥194.46 Million | CN¥229.71 Million | CN¥269.39 Million | CN¥252.30 Million |
| Property, Plant & Equipment | — | — | — | CN¥556.49 Million | CN¥452.20 Million |
| Goodwill | CN¥12.02 Million | CN¥309.71K | CN¥26.14 Million | CN¥26.14 Million | CN¥26.14 Million |
| Total Liabilities | CN¥896.55 Million | CN¥986.42 Million | CN¥1.03 Billion | CN¥1.01 Billion | CN¥863.90 Million |
| Total Current Liabilities | CN¥855.17 Million | CN¥940.01 Million | CN¥977.86 Million | CN¥958.06 Million | CN¥813.48 Million |
| Long-term Debt | — | — | — | CN¥3.00 Million | CN¥27.78 Million |
| Net Debt | CN¥166.01 Million | CN¥225.60 Million | CN¥159.67 Million | CN¥-55.23 Million | CN¥-472.44 Million |
| Total Stockholder Equity | CN¥2.75 Billion | CN¥2.62 Billion | CN¥2.56 Billion | CN¥2.48 Billion | CN¥2.11 Billion |
| Retained Earnings | CN¥1.73 Billion | CN¥1.62 Billion | CN¥1.51 Billion | CN¥1.45 Billion | CN¥1.12 Billion |
Getein Biotech Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Getein Biotech Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥392.59 Million | CN¥423.00 Million | CN¥333.22 Million | CN¥482.96 Million | CN¥432.36 Million |
| Capital Expenditures | CN¥150.58 Million | CN¥156.40 Million | CN¥258.13 Million | CN¥217.44 Million | CN¥179.60 Million |
| Free Cash Flow | CN¥242.01 Million | CN¥266.60 Million | CN¥75.09 Million | CN¥265.51 Million | CN¥252.77 Million |
| Investing Cash Flow | — | CN¥-348.12 Million | CN¥-356.83 Million | CN¥-760.44 Million | CN¥-254.63 Million |
| Financing Cash Flow | — | CN¥-213.67 Million | CN¥-145.88 Million | CN¥-45.88 Million | CN¥-28.93 Million |
| Dividends Paid | CN¥103.24 Million | CN¥110.98 Million | CN¥219.40 Million | CN¥123.17 Million | CN¥93.16 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥85.36 Million | CN¥93.65 Million | CN¥93.08 Million | CN¥70.35 Million | CN¥49.40 Million |
| Change in Cash | CN¥-41.12 Million | CN¥-132.89 Million | CN¥-157.81 Million | CN¥-304.16 Million | CN¥147.78 Million |
Getein Biotech Inc Earnings History — EPS Actual vs. Analyst Estimates
Track Getein Biotech Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 22, 2025 | — | — | — |
| Oct 30, 2024 | — | — | — |
| Apr 27, 2023 | 0.05 | — | — |
| Oct 27, 2022 | 0.29 | — | — |
| Aug 24, 2022 | 0.22 | — | — |
| Apr 27, 2022 | 0.28 | — | — |
| Oct 29, 2021 | 0.23 | — | — |
| Aug 17, 2021 | 0.18 | 0.18 | +0.00% |